Related Experiment Video
Updated: Nov 27, 2025
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Pathogenesis of Cholangiocarcinoma
Pedro M Rodrigues1,2, Paula Olaizola1, Nuno A Paiva1
1Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastian, Spain; email: jesus.banales@biodonostia.org, pedro.rodrigues@biodonostia.org.
Cholangiocarcinoma (CCA), a rare but increasing cancer, presents challenges due to its silent nature, aggressiveness, and chemoresistance. This review explores CCA pathogenesis, molecular alterations, and therapeutic strategies to improve patient outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Cholangiocarcinoma (CCA) is a biliary tree malignancy with increasing global incidence.
- Early-stage CCA is often asymptomatic, contributing to late diagnosis and poor prognosis.
- Tumor aggressiveness, heterogeneity, and chemoresistance limit current treatment efficacy.
Purpose of the Study:
- To review current findings on the pathogenesis of cholangiocarcinoma.
- To summarize molecular and genetic alterations driving CCA development.
- To discuss therapeutic strategies and chemoresistance mechanisms in CCA.
Main Methods:
- Comprehensive literature review of recent studies on cholangiocarcinoma.
- Analysis of research on CCA etiology, pathogenesis, and cellular origins.
- Synthesis of data on genomic, epigenetic, and molecular alterations in CCA.
Main Results:
- CCA pathogenesis involves complex molecular and genetic changes.
- Tumor heterogeneity and chemoresistance are significant challenges in CCA treatment.
- Emerging therapies show promise but require further investigation.
Conclusions:
- Understanding CCA pathogenesis is crucial for developing effective therapies.
- Targeting molecular alterations and overcoming chemoresistance are key research areas.
- Continued research is essential to improve the dismal prognosis of cholangiocarcinoma.
More Related Videos
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:18Cancer